Androgenetic Alopecia (AGA), commonly known as “seborrheic alopecia” or “male pattern baldness,” is the most common type of hair loss. This condition can occur in both men and women, but with different manifestations—men typically start with a receding frontal hairline and thinning at the crown, while women primarily present with diffuse thinning on the top of the scalp.
Many people observe that if their father or grandfather is bald, they themselves seem to have a higher likelihood of becoming bald. Behind this intuitive perception lies solid scientific evidence—genetic factors play a central role in the development of androgenetic alopecia.
Genetic factors determine the sensitivity of hair follicles to androgens, which is one of the fundamental mechanisms of androgenetic alopecia. Androgens (mainly testosterone) are converted into dihydrotestosterone (DHT) under the action of 5α-reductase. DHT binds to androgen receptors in the hair follicles, leading to gradual miniaturization of the follicles—originally thick, long terminal hairs become thin, short vellus hairs and eventually fall out.
One of the key genes is the **androgen receptor gene (AR gene)** located on the X chromosome. The protein encoded by this gene is the androgen receptor, and its polymorphisms directly affect the sensitivity of hair follicles to androgens. Since males have only one X chromosome (inherited from the mother), variations in the AR gene have a particularly significant impact on men. This is why some people often hear the saying that “baldness is inherited from the mother”—although not entirely accurate, it does have a genetic basis.
In addition to the AR gene, genome-wide association studies (GWAS) have identified multiple gene loci associated with androgenetic alopecia, including genes on chromosome 20 (affecting 5α-reductase activity) as well as genes involved in the Wnt signaling pathway, apoptosis, and other processes. This indicates that androgenetic alopecia is a **polygenic** trait, not determined by a single gene.
Family history is one of the most important clinical indicators for assessing an individual’s risk of hair loss. A study of male twins showed that the hair loss patterns of monozygotic (identical) twins were highly consistent, while those of dizygotic (fraternal) twins showed significantly lower consistency, corroborating the contribution of genetic factors from a genetic perspective. It should be emphasized that what is inherited is only “susceptibility,” not “inevitability”—people with a family history do not necessarily develop obvious hair loss, while those without a family history may still develop the condition due to other factors.
Racial differences also point to the role of genetic factors. Studies have shown that the incidence of male androgenetic alopecia is highest in Caucasians (approximately 50% develop noticeable hair loss by age 50), relatively lower in Asians and Native Americans, and intermediate in individuals of African descent. These differences cannot be explained solely by environment or lifestyle and are more likely related to the genetic backgrounds of different populations.
However, genetics does not equate to “destiny.” Androgenetic alopecia results from the interaction of genetic susceptibility with multiple factors such as environment, hormone levels, and age. Even in individuals carrying high-risk genetic variants, the degenerative process of hair follicles requires the continuous action of androgens and is modulated by non-genetic factors such as inflammatory responses, scalp microcirculation, and life stress. Therefore, a healthy lifestyle and early intervention can delay or mitigate the progression of hair loss.
From the perspective of evidence-based medicine, there is currently no cure targeting the genetic factors. However, existing treatments—such as oral finasteride (inhibiting 5α-reductase), topical minoxidil, low-level laser therapy, and hair transplant surgery—can effectively intervene in the disease course. The targets of these treatments are precisely the androgen-hair follicle interaction processes caused by genetic factors.
It is worth noting that commercially available “genetic testing for hair loss prediction” products have limited clinical value. Although testing can reveal certain risk genotypes, it cannot accurately predict the timing, speed, or severity of hair loss, nor can it replace evaluation by a professional physician.
**For reference only, does not constitute medical advice.** If you are concerned about hair loss, it is recommended to first consult a dermatologist to obtain an accurate diagnosis through medical history, family history, and scalp examination, and then develop an individualized management plan.